TITLE

Drugs in the News

PUB. DATE
May 2009
SOURCE
Clarendon Enterprise (TX);5/14/2009, Vol. 20 Issue 20, p5
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article offers information on a drug for head lice which was approved by the U.S. Food and Drug Administration.
ACCESSION #
41133148

 

Related Articles

  • New option available for treating head lice.  // Infectious Diseases in Children;Aug2009, Vol. 22 Issue 8, p46 

    The article reports on the approval by the U.S. Food and Drug Administration on Ulesfia 5% benzyl alcohol lotion as the first non-neurotoxic topical head lice prescription treatment for use in children aged 6 months and older.

  • Labeling changes suggested for lice tx.  // Dermatology Times;May96, Vol. 17 Issue 5, p4 

    Reports that the Food and Drug Administration has recommended labeling changes for childhood lice treatments containing the pesticide lindane.

  • FDA approves topical lice treatment spinosad for patients aged 4 years and older.  // Infectious Diseases in Children;Feb2011, Vol. 24 Issue 2, p5 

    The article reports on the approval by the U.S. Food and Drug Administration (FDA) of the topical application of spinosad for head lice treatment in patients four years old and above.

  • Natroba.  // Pharmaceutical Representative;Feb2011, Vol. 41 Issue 2, p11 

    The article presents the U.S. Food and Drug Administration's (FDA) approval of Natroba Topical Suspension 0.9 percent from ParaPro LLC, designed for head lice infestation treatment for patients 4 years old and above.

  • Treatment for Head Lice From ParaPRO Gets OK.  // Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p50 

    The article reports on the approval of ParaPRO LLC's Natroba topical suspension to eliminate head lice by the U.S. Food and Drug Adminstration (FDA).

  • FDA and JAMA raise eyebrows at efficacy of head lice remedies.  // Drug Store News;8/12/2002, Vol. 24 Issue 10, p22 

    Deals with the proposal of the U.S. Food and Drug Administration to redesign the labeling for lice-removing treatments in order to improve the efficacy of over-the-counter lice remedies. Information on the labeling changes proposed by the U.S. agency; Reaction of lice to lice-removal treatments;...

  • New Head Lice Treatments Sought.  // Dermatology Nursing;Dec2002, Vol. 14 Issue 6, p411 

    Reports on the development of head lice treatment in the U.S. as of December 2002. Over-the-counter pediculicides approved by the Food and Drugs Administration; Examples of creative therapies developed by patients with head lice problems; Effectiveness of the prescription products approved by...

  • Changing Labels: Lice Treatments...  // Child Health Alert;Apr2004, Vol. 22, p2 

    Deals with the changes in the labels of lice treatment products mandated by the U.S. Food and Drug Administration in 2004. Reason for the move; Information content of the labels.

  • FDA actions in brief.  // Formulary;May2009, Vol. 44 Issue 5, p135 

    The article offers news briefs related to the approved drugs by the U.S. Food and Drug Administration. Aremether, manufactured by Novartis and Coartem, has been approved for the treatment of uncomplicated infections caused by Plasmodium falciparum. Escitalopram, produced by Lexapro and Forest,...

Share

Other Topics